methylation
The firm said its DNA methylation testing technology could be applied to dozens of cancers and potentially some non-cancer chronic diseases.
Recent meeting presentations have offered a first look at the company's targeted methylation approach and the test's high sensitivity in early-stage cancers.
Grail, Nonprofits to Explore Multi-Cancer Early Detection Testing in Underserved Populations
Grail has entered into a research collaboration with nonprofits the Whitman-Walker Institute and Cancer Support Community to advance health equity in cancer screening.
Inex Innovate to Launch PCR-Based Endometrial Cancer Detection Test
The Singapore-based company plans to launch the epiHera test in August, following interim results from a clinical study with researchers at the Chinese University of Hong Kong.
Findings from two clinical studies were reported at Digestive Disease Week earlier this month that supported use of the firm's EsoCheck device and EsoGuard test.